<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">J Proteomics Bioinform</journal-id>
			<journal-id journal-id-type="publisher-id">opg</journal-id>						
			<journal-title>Journal of Proteomics &amp; Bioinformatics</journal-title>			 
			<issn pub-type="epub">0974-276X</issn>
			<publisher>
				<publisher-name>OMICS Publishing Group</publisher-name>
				<publisher-loc>India, USA</publisher-loc>
			</publisher>
		</journal-meta>
		<article-meta>			
			<article-id pub-id-type="publisher-id">000063</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Research Article</subject>
				</subj-group>
				<subj-group subj-group-type="Discipline">
					<subject>Biochemistry</subject>
				</subj-group>
				<subj-group subj-group-type="System Taxonomy">
					<subject>Proteomics</subject>
					<subject>Bioinformatics</subject>
					<subject>Genomics</subject>
					<subject>Transcriptomics</subject>
					<subject>Biomarkers</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Comparative Modeling Of Viral Protein R (Vpr) From Human Immunodeficiency Virus 1 (Hiv 1)</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Renganathan</surname>
						<given-names>Seenivasagan</given-names>
					</name>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Renganathan</surname>
						<given-names>Kasimani</given-names>
					</name>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Parthiban</surname>
						<given-names>Marimuthu</given-names>
					</name>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Ramamoorthy</surname>
						<given-names>Kalidoss</given-names>
					</name>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Piramanayagam</surname>
						<given-names>Shanmughavel</given-names>
					</name>
					<xref ref-type="corresp" rid="cor1">&ast;</xref>
				</contrib>
				</contrib-group>			
			<aff id="af1"> Department of Bioinformatics, DBT-BIF Facility, Bharathiar University, Coimbatore – 641 046</aff>
			<author-notes>
				<corresp id="cor1">&ast; To whom correspondence should be addressed: Dr. P. Shanmughavel, Ph.D., Department of Bioinformatics, DBT-BIF Facility, Bharathiar University, Coimbatore – 641 046, Ph: +91-422-2422655; Fax : +91-244-2422387;  E-mail: <email>shanvel_99@yahoo.com</email></corresp>
			</author-notes>
			<pub-date pub-type="collection">
			     <month>05</month>
				 <year>2008</year>
			</pub-date>
			<pub-date pub-type="epub">
				<day>20</day>
				<month>05</month>
				<year>2008</year>
			</pub-date>			
			<volume>1</volume>
			<issue>2</issue>
			<fpage>073</fpage>
			<lpage>076</lpage>
			<history>
			<date date-type="received">
			     <day>21</day>
				 <month>04</month>
				 <year>2008</year>
			</date>
			<date date-type="accepted">
			      <day>14</day>
				  <month>05</month>
				  <year>2008</year>
			</date>
			</history>
			<permissions>				 
			<copyright-statement><bold>Copyright:</bold> &copy; 2008 Seenivasagan R, etal.</copyright-statement>
			<copyright-year>2008</copyright-year>
			<license license-type="open access">
			<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
			</license>
			</permissions>						
			<abstract>
				<p>During Human Immunodeficiency Virus infection interactions take place between host and the pathogen. This interaction mainly determines the efficiency of viral infection and the disease progression. Human Immunodeficiency Virus infected cells responds to several antiviral immune mechanisms such as innate, cellular and humoral immune antiviral defense. This virus has also gained resistance to suppress these host cellular responses. Out of many self resistance mechanisms, Viral protein R (VpR) occupies a significant role, such as nuclear transport of the viral pre-integration complex, activation of viral transcription, induction of cell cycle and apoptosis of the host cells. Apart from these specific roles, the function of VpR remains mystery for the structural bioinformatics. The comparative modeling approach is used to predict the structure of a VpR using NMR structure of the HIV-1 regulatory protein as the template (PDB ID: 1ESX: A). The theoretical structure of VpR is generated using Modeller9v1, a program for comparative modeling of protein using special restraints. This theoretical structure believes to paves the way for the novel lead synthesis.</p>
			</abstract>
			<kwd-group>
				<kwd>Viral protein R (VpR)</kwd>
				<kwd>Human immunodeficiency virus-1 (HIV-1)</kwd>
				<kwd>Structural Bioinformatics</kwd>
				<kwd>Comparative modeling</kwd>
				<kwd>Structure Based Drug Design</kwd>
			</kwd-group>
			 <custom-meta-wrap>
				<custom-meta>
					<meta-name>citation</meta-name>
					<meta-value>Renganathan S, Renganathan K, Parthiban M, Ramamoorthy K, Piramanayagam S (2008) Comparative Modeling Of Viral Protein R (Vpr) From Human Immunodeficiency Virus 1 (Hiv 1)
					</meta-value>
				</custom-meta>
			</custom-meta-wrap>
		</article-meta>		 
	</front>
	<body>
	<sec id="s1">
		<title>Introduction</title>
			<p>Human immunodeficiency virus (HIV) belongs to retroviral family which leads to Acquired Immuno Deficiency Syndrome which ultimately leads to failure in immune response. There are two types of HIV infecting humans: HIV-1 and HIV-2. HIV-1 is more a virulent and easily transmitted than in case o HIV-2 which is less transmitted. HIV-1 possess the following virion particle is Vif, VpR, Nef, p7 and viral protease. VpR strands for, “Viral Protein R” a 96 residue polypeptide of 14 kDa protein, (<xref ref-type="bibr" rid="r10">Hoch J. et al.1995</xref>), (<xref ref-type="bibr" rid="r12">Lang SM et al. 1993</xref>). VpR plays an important role in regulating nuclear import of the HIV-1 preintegration complex (<xref ref-type="bibr" rid="r9">Heinzinger NK et al. 1994</xref>). VpR is an integral part of viral particles suggesting an important role in early stages of infection (<xref ref-type="bibr" rid="r3">Cohen EA et al, 1990</xref>), (<xref ref-type="bibr" rid="r25">Yu XF et al, 1990</xref>), (<xref ref-type="bibr" rid="r14">Lu YL et al, 1993</xref>), (<xref ref-type="bibr" rid="r4">Emerman M, 1996</xref>) which is required for viral replication in non-dividing cells such as macrophages (<xref ref-type="bibr" rid="r1">Agostini I et al, 2002</xref>) and also induces cell cycle arrest and apoptosis in proliferating cells, which leads to immune dysfunction (<xref ref-type="bibr" rid="r8">He J et al, 1995</xref>), (<xref ref-type="bibr" rid="r11">Jowett JB et al, 1995</xref>), (<xref ref-type="bibr" rid="r18">Re F et al, 1995</xref>), (<xref ref-type="bibr" rid="r19">Rogel ME et al, 1995</xref>). Recombinant, over expressed VpR forms ion channels in <italic>E. coli</italic> which is permeable to Na+ ions (<xref ref-type="bibr" rid="r16">Piller SC et al, 1999</xref>), (<xref ref-type="bibr" rid="r17">Piller SC et al, 1999</xref>). Different cellular proteins are reported to interact with VpR : transcription factor Sp1 (<xref ref-type="bibr" rid="r22">Wang L et al, 1995</xref>), uracil DNA glycosylase (UNG) (<xref ref-type="bibr" rid="r2">Bouhamdan M et al, 1996</xref>), HHR23A – a protein implicated in DNA repair (<xref ref-type="bibr" rid="r24">Withers- Ward ES et al, 1997</xref>), importin – a nuclear pore protein Nsp1p (<xref ref-type="bibr" rid="r21">Vodicka MA et al, 1998</xref>), and many others. VpR play multiple functions such as, cell cycle progression during the virus life cycle, regulation of apoptosis, and the transactivation of the HIV-LTR as well as host cell genes (<xref ref-type="bibr" rid="r13">Le Rouzic E, Benichou S, 2005</xref>). VpR is conserved in both HIV-1 and HIV-2.</p>
			<p>The NMR structure of the template protein has revealed the structural information of VpR using comparative modeling technique. The template structure is characterized by a well defined gamma turn (14-16) - alpha helix (17-33)- turn (34-36) followed by a alpha helix (40-48) –loop(49-54)- alpha helix (55- 83) domain and ends with a very flexible C terminal sequence (<xref ref-type="bibr" rid="r23">Wecker K et al, 2002</xref>).</p>
	</sec>
	<sec sec-type="methods">
		<title>Materials and Methods</title>
			<sec>
				<title>Sequence Alignment</title>
					<p>The protein sequence of VpR was retrieved form from the NCBI database (P0C1P5) which has 96 amino acids. The target sequence was searched for similar sequence using the BLAST (Basic Local Alignment Search Tool), against Protein Database (PDB). The BLAST results yielded NMR structure of HIV-1 regulatory protein R VpR with 85% similarity to our target protein.</p>
			</sec>
			<sec>
				<title>Comparative Modling</title>
					<p>The theoretical structure of VpR is generated using Modeller-9v1 for comparative modeling of protein structure prediction (<xref ref-type="bibr" rid="r5">Eswar N et al, 2006</xref>), (<xref ref-type="bibr" rid="r15">Martí-Renom MA et al, 2000</xref>). It implements comparative structural modeling by conforming special restraints (<xref ref-type="bibr" rid="r20">Sali A, Blundell TL. 1993</xref>),(<xref ref-type="bibr" rid="r6">Fiser A et al, 2000</xref>).</p>
			</sec>
			<sec>
				<title>Modle Refinement</title>
					<p>Theoretical structure of VrP is verified for the steroschemical clashes by subjecting the model to SwissPDB Viewer. The energy minimization with a harmonic constraint of 100kj/mol/A2, was applied for all protein atoms, using the Steepest- Decent and Conjugate Gradient technique to eliminate bad contacts between protein atoms. Computations were carried out with the GROMOS96 in Swiss-PDB Viewer. Backbone conformation was evaluated by inspecting Psi/Phi Ramachandran plot was obtained from the PROCHECK analysis.</p>
			</sec>
	</sec>
	<sec id="s3">
		<title>Result and Discussion</title>
			<p>VpR involved in key regulation of nuclear import of HIV-1 preintegration complex, a significant role in early stages of integration, viral replication in non-dividing cells, induces cell cycle arrest as well as apoptosis in proliferating cells. </p>
			<sec>
				<title>Model Building</title>
					<p>Based on the results obtained from the BLAST program VpR from HIV-1 was selected as template. The use of several independent third generation algorithms of secondary structure prediction suggests that the theoretical structure of VpR comprises of a helical structure. We used the approach of comparative modeling based on the template of a known structure. This approach is best suitable when a homolog of the target is known. The prediction of typical VpR exhibited 85% similarity which inturn means that the true accuracy of our prediction could be a little higher identity of the prediction when compared with the template. Energy minimizations were performed using Deep View with GROMOS96 parameters which did not significantly modify the initial models.</p>
			</sec>
			<sec>
				<title>Secondary Structure Prediction</title>
					<p>The secondary structure of VpR protein was predicted by SOPMA (Self Optimized Prediction Method with Alignment) which correctly predicts 69.5% of amino acids for a three-state description of the secondary structure prediction (alpha helix, beta-sheet, and coil) (<xref ref-type="bibr" rid="r7">Geourjon C, Deléage G. 1995</xref>). The most of the regions are Alpha helix (HH): 45.83%, the extended strands (EE):11.46% and the random coils (CC): 42.71%. SOPMA resulting for both target and template has more or less similar secondary structural elements except two places. Where 45th and 46th place in case of target forms continious helix where in case of template it forms extended sheet. The position at 48 to 51 where in target forms coil, in case of template which is a turn (<xref ref-type="fig" rid="g1">Figure 1</xref>),(<xref ref-type="fig" rid="g2">Figure 2</xref>).</p>
					<fig id="g1">
					<label>Figure 1</label>
					<caption>
						<title>Comparative modeled protein structure showed in PyMol (protein structure viewer). Protein which forms alpha helices (17-33), (40- 48), (55-83), turns and coil was showed.</title>
					</caption>
					<graphic xlink:href="JPB-01-073-g001.tif"/>
				</fig>
				<fig id="g2">
					<label>Figure 2</label>
					<caption>
						<title>Sequence alignment of both target and template sequence with SOPMA secondary structural prediction. Amino acids with red color are different from the template sequence.SOPMA secondary structure prediction of V pr protein. </title>
					</caption>
					<graphic xlink:href="JPB-01-073-g002.tif"/>
				</fig>					
			</sec>
			<sec>
				<title>Ramachandran Plot Analysis</title>
					<p>The theoretical structure of VpR was energy minimized and subjected to procheck web interface for sterochemical analysis. (<xref ref-type="fig" rid="g3">Figure 3</xref>). The most of the residues were in favored regions [A,B,L] -68 (85 %); residues in additional allowed regions [a, b, l, p] – 9 (11.2 %); residues in generously allowed regions [-a, -b, -l, -p ] - 2 (2.5 %) ; residues in disallowed region 1 (1.2 %); number of non-glycine and non-proline residues -80 (100 %) number of end residues (excl. Gly and Pro) – 2; Number of glycine residues (shown as triangles) – 9; number of proline residues– 5; Total number of residues – 96.</p>
			<fig id="g3">
					<label>Figure 3</label>
					<caption>
						<title>Secondary structure prediction of VpR protein. Sequence alignment of both template and target sequence with SOPMA secondary structure prediction. Amino acids with red color were showed changes in template from target sequence.</title>
					</caption>
					<graphic xlink:href="JPB-01-073-g003.tif"/>
				</fig>				
			</sec>			 
	</sec>
	<sec id="s4">
		<title>Conslusion</title>
			<p>Based on the Template structure it is clearly observed that the theoretical structure generated is structurally similar to the template structure which is highly sufficient for the development of specific ligand for VpR. Our model of VpR is only a predictive, and needed to be confirmed experimentally, testing in vivo the activity of ligand candidates which could constitute an important first step towards the validation of our model as tools for the discovery of novel VpR agonist. This modeled structure can be used to predict the molecular function, the active sites which haven’t studied much. The predicted 3D model of the VpR of HIV will be very useful in wet laboratory while studying the real structure of the protein.</p>
	</sec>		
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="r1">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Agostini</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Popov</surname>
							<given-names>S</given-names>
						</name>	
						<name>
							<surname>Hao</surname>
							<given-names>T</given-names>
						</name>	
						<name>
							<surname>Li</surname>
							<given-names>JH</given-names>
						</name>
						<name>
							<surname>Dubrovsky</surname>
							<given-names>L</given-names>
						</name><etal/>																	
				    </person-group>
					<year>2002</year>
					<article-title>Phosphorylation of VpR regulates HIV type 1 nuclear import and macrophage infection</article-title>
					<source>AIDS Res Hum Retroviruses</source>
					<volume>18</volume>
					<fpage>283</fpage>
					<lpage>288</lpage>
				</citation>
			</ref>
			<ref id="r2">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Bouhamdan</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Benichou</surname>
							<given-names>S</given-names>
						</name>	
						<name>
							<surname>Rey</surname>
							<given-names>F</given-names>
						</name>	
						<name>
							<surname>Navarro</surname>
							<given-names>JM</given-names>
						</name>
						<name>
							<surname>Agostini</surname>
							<given-names>I</given-names>
						</name><etal/>																	
				    </person-group>
					<year>1996</year>
					<article-title>Human immunodeficiency virus type 1 VpR protein binds to the uracil DNA glycosylase DNA repair enzyme</article-title>
					<source>J Virol</source>
					<volume>70</volume>
					<fpage>697</fpage>
					<lpage>704</lpage>
				</citation>
			</ref>
			<ref id="r3">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Cohen</surname>
							<given-names>EA</given-names>
						</name>
						<name>
							<surname>Dehni</surname>
							<given-names>G</given-names>
						</name>	
						<name>
							<surname>Sodroski</surname>
							<given-names>JG</given-names>
						</name>	
						<name>
							<surname>Haseltine</surname>
							<given-names>WA</given-names>
						</name>																					
				    </person-group>
					<year>1990</year>
					<article-title>Human immunodeficiency virus VpR product is a virion-associated regulatory protein</article-title>
					<source>J Virol</source>
					<volume>64</volume>
					<fpage>3097</fpage>
					<lpage>3099</lpage>
				</citation>
			</ref>
			<ref id="r4">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Emerman</surname>
							<given-names>M</given-names>
						</name>																						
				    </person-group>
					<year>1996</year>
					<article-title>HIV-1,VpR and the cell cycle</article-title>
					<source>Curr Biol</source>
					<volume>6</volume>
					<fpage>1096</fpage>
					<lpage>1103</lpage>
				</citation>
			</ref>
			<ref id="r5">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Eswar</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Marti</surname>
							<given-names>RMA</given-names>
						</name>	
						<name>
							<surname>Webb</surname>
							<given-names>B</given-names>
						</name>	
						<name>
							<surname>Madhusudhan</surname>
							<given-names>MS</given-names>
						</name>
						<name>
							<surname>Eramian</surname>
							<given-names>D</given-names>
						</name><etal/>																						
				    </person-group>
					<year>2006</year>
					<article-title>Comparative Protein Structure Modeling using MODELLER. Curr Protocols in Bioinformatics</article-title>
					<source>John Wiley &amp; Sons</source>
					<volume>5</volume>
					<fpage>6.1</fpage>
					<lpage>6.30</lpage>
				</citation>
			</ref>
			<ref id="r6">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Fiser</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Do</surname>
							<given-names>RK</given-names>
						</name>	
						<name>
							<surname>Sali</surname>
							<given-names>A</given-names>
						</name>																										
				    </person-group>
					<year>2000</year>
					<article-title>Modeling of loops in protein structures</article-title>
					<source>Protein Sci</source>
					<volume>9</volume>
					<fpage>1753</fpage>
					<lpage>1773</lpage>
				</citation>
			</ref>
			<ref id="r7">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Geourjon</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Deléage</surname>
							<given-names>G</given-names>
						</name>																														
				    </person-group>
					<year>1995</year>
					<article-title>SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments</article-title>
					<source>Comput Appl Biosci</source>
					<volume>11</volume>
					<fpage>681</fpage>
					<lpage>684</lpage>
				</citation>
			</ref>
			<ref id="r8">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>He</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Choe</surname>
							<given-names>S</given-names>
						</name>	
						<name>
							<surname>Walker</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Di Marzio</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Morgan</surname>
							<given-names>DO</given-names>
						</name><etal/>																																			
				    </person-group>
					<year>1995</year>
					<article-title>SHuman immunodeficiency virus type 1 viral protein R (VpR) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity</article-title>
					<source>J Virol</source>
					<volume>69</volume>
					<fpage>6705</fpage>
					<lpage>6711</lpage>
				</citation>
			</ref>
			<ref id="r9">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Heinzinger</surname>
							<given-names>NK</given-names>
						</name>
						<name>
							<surname>Bukinsky</surname>
							<given-names>MI</given-names>
						</name>	
						<name>
							<surname>Haggerty</surname>
							<given-names>SA</given-names>
						</name>
						<name>
							<surname>Ragland</surname>
							<given-names>AM</given-names>
						</name>
						<name>
							<surname>Kewalramani</surname>
							<given-names>V</given-names>
						</name><etal/>																																			
				    </person-group>
					<year>1991</year>
					<article-title>The VpR protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells</article-title>
					<source>Proc Natl Acad Sci USA</source>
					<volume>91</volume>
					<fpage>7311</fpage>
					<lpage>7315</lpage>
				</citation>
			</ref>
			<ref id="r10">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Hoch</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Lang</surname>
							<given-names>SM</given-names>
						</name>	
						<name>
							<surname>Weeger</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Stahl Hennig</surname>
							<given-names>C,</given-names>
						</name>
						<name>
							<surname>Coulibaly</surname>
							<given-names>C</given-names>
						</name><etal/>																																			
				    </person-group>
					<year>1995</year>
					<article-title>VpR deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys</article-title>
					<source>J Virol</source>
					<volume>69</volume>
					<fpage>4807</fpage>
					<lpage>4813</lpage>
				</citation>
			</ref>
			<ref id="r11">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Jowett</surname>
							<given-names>JB</given-names>
						</name>
						<name>
							<surname>Planelles</surname>
							<given-names>V</given-names>
						</name>	
						<name>
							<surname>Poon</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Shah</surname>
							<given-names>NP</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>ML</given-names>
						</name><etal/>																																			
				    </person-group>
					<year>1995</year>
					<article-title>The human immunodeficiency virus type 1 VpR gene arrests infected T cells in the G2 + M phase of the cell cycle</article-title>
					<source>J Virol</source>
					<volume>69</volume>
					<fpage>6304</fpage>
					<lpage>6313</lpage>
				</citation>
			</ref>
			<ref id="r12">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Lang</surname>
							<given-names>SM</given-names>
						</name>
						<name>
							<surname>Weeger</surname>
							<given-names>M</given-names>
						</name>	
						<name>
							<surname>Stahl Hennig</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Coulibaly</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Hunsmann</surname>
							<given-names>G</given-names>
						</name><etal/>																																			
				    </person-group>
					<year>1993</year>
					<article-title>Importance of VpR for infection of rhesus monkeys with simian immunodeficiency virus</article-title>
					<source>J Virol</source>
					<volume>67</volume>
					<fpage>902</fpage>
					<lpage>912</lpage>
				</citation>
			</ref>
			<ref id="r13">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Le Rouzic</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Benichou</surname>
							<given-names>S</given-names>
						</name>																																							
				    </person-group>
					<year>2005</year>
					<article-title>The VpR protein from HIV-1: distinct roles along the viral life cycle</article-title>
					<source>Retrovirology</source>
					<volume>2</volume>
					<fpage>11</fpage>					
				</citation>
			</ref>
			<ref id="r14">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Lu</surname>
							<given-names>YL</given-names>
						</name>
						<name>
							<surname>Spearman</surname>
							<given-names>P</given-names>
						</name>	
						<name>
							<surname>Ratner</surname>
							<given-names>L</given-names>
						</name>																																									
				    </person-group>
					<year>1993</year>
					<article-title>Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions				</article-title>
					<source>J Virol</source>
					<volume>67</volume>
					<fpage>6542</fpage>
					<lpage>6550</lpage>
				</citation>
			</ref>
			<ref id="r15">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Martí Renom</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Stuart</surname>
							<given-names>AC</given-names>
						</name>	
						<name>
							<surname>Fiser</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Sánchez</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Melo</surname>
							<given-names>F</given-names>
						</name><etal/>																																													
				    </person-group>
					<year>2000</year>
					<article-title>Comparative protein structure modeling of genes and genomes</article-title>
					<source>Annu Rev Biophys Biomol Struct</source>
					<volume>29</volume>
					<fpage>291</fpage>
					<lpage>325</lpage>
				</citation>
			</ref>
			<ref id="r16">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Piller</surname>
							<given-names>SC</given-names>
						</name>
						<name>
							<surname>Ewart</surname>
							<given-names>GD</given-names>
						</name>	
						<name>
							<surname>Jans</surname>
							<given-names>DA</given-names>
						</name>
						<name>
							<surname>Gage</surname>
							<given-names>PW</given-names>
						</name>
						<name>
							<surname>Cox</surname>
							<given-names>GB</given-names>
						</name>																																													
				    </person-group>
					<year>1999</year>
					<article-title>The amino-terminal region of VpR from human immunodeficiency virus type 1 forms ion channels and kills neurons</article-title>
					<source>J Virol</source>
					<volume>73</volume>
					<fpage>4230</fpage>
					<lpage>4238</lpage>
				</citation>
			</ref>
			<ref id="r17">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Piller</surname>
							<given-names>SC</given-names>
						</name>
						<name>
							<surname>Ewart</surname>
							<given-names>GD</given-names>
						</name>	
						<name>
							<surname>Premkumar</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Cox</surname>
							<given-names>GB</given-names>
						</name>
						<name>
							<surname>Gage</surname>
							<given-names>PW</given-names>
						</name>																																													
				    </person-group>
					<year>1996</year>
					<article-title>VpR protein of human immunodeficiency virus type 1forms cation-selective channels in planar lipid bilayers</article-title>
					<source>Acad Sci USA</source>
					<volume>93</volume>
					<fpage>11</fpage>
					<lpage>15</lpage>
				</citation>
			</ref>
			<ref id="r18">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Re</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Braaten</surname>
							<given-names>D</given-names>
						</name>	
						<name>
							<surname>Franke</surname>
							<given-names>EK</given-names>
						</name>
						<name>
							<surname>Luban</surname>
							<given-names>J</given-names>
						</name>																																															
				    </person-group>
					<year>1995</year>
					<article-title>Human immunodeficiency virus type 1 VpR arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B</article-title>
					<source>J Virol</source>
					<volume>69</volume>
					<fpage>6859</fpage>
					<lpage>6864</lpage>
				</citation>
			</ref>
			<ref id="r19">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Rogel</surname>
							<given-names>ME</given-names>
						</name>
						<name>
							<surname>Wu</surname>
							<given-names>LI</given-names>
						</name>	
						<name>
							<surname>Emerman</surname>
							<given-names>M</given-names>
						</name>																																																		
				    </person-group>
					<year>1995</year>
					<article-title>The human immunodeficiency virus type 1 VpR gene prevents cell proliferation during chronic infection</article-title>
					<source>J Virol</source>
					<volume>69</volume>
					<fpage>882</fpage>
					<lpage>888</lpage>
				</citation>
			</ref>
			<ref id="r20">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Sali</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Blundell</surname>
							<given-names>TL</given-names>
						</name>																																																						
				    </person-group>
					<year>1993</year>
					<article-title>Comparative protein modelling by satisfaction of spatial restraints</article-title>
					<source>J Mol Biol</source>
					<volume>234</volume>
					<fpage>779</fpage>
					<lpage>815</lpage>
				</citation>
			</ref>
			<ref id="r21">
				<citation citation-type="journal">
					<person-group>

						<name>
							<surname>Vodicka</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Koepp</surname>
							<given-names>DM</given-names>
						</name>
						<name>
							<surname>Silver</surname>
							<given-names>PA</given-names>
						</name>
						<name>
							<surname>Emerman</surname>
							<given-names>M</given-names>
						</name>																																																							
				    </person-group>
					<year>1998</year>
					<article-title>HIV-1 VpR interacts with the nuclear transport pathway to promote macrophage infection</article-title>
					<source>Genes Dev</source>
					<volume>12</volume>
					<fpage>175</fpage>
					<lpage>185</lpage>
				</citation>
			</ref>
			<ref id="r22">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Wang</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Mukherjee</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Jia</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Narayan</surname>
							<given-names>O</given-names>
						</name>
						<name>
							<surname>Zhao</surname>
							<given-names>LJ</given-names>
						</name>																																																								
				    </person-group>
					<year>1995</year>
					<article-title>Interaction of virion protein VpR of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat</article-title>
					<source>J Biol Chem</source>
					<volume>270</volume>
					<fpage>25564</fpage>
					<lpage>25569</lpage>
				</citation>
			</ref>
			<ref id="r23">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Wecker</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Morellet</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Bouaziz</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Roques</surname>
							<given-names>BP</given-names>
						</name>																																																										
				    </person-group>
					<year>2002</year>
					<article-title>NMR structure of the HIV-1 regulatory protein VpR in H2O/trifluoroethanol. Comparison with the VpR N-terminal (1-51) and C-terminal (52-96) domains</article-title>
					<source>Eur J Biochem</source>
					<volume>269</volume>
					<fpage>3779</fpage>
					<lpage>3788</lpage>
				</citation>
			</ref>
			<ref id="r24">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Withers</surname>
							<given-names>WES</given-names>
						</name>
						<name>
							<surname>Jowett</surname>
							<given-names>JB</given-names>
						</name>
						<name>
							<surname>Stewart</surname>
							<given-names>SA</given-names>
						</name>
						<name>
							<surname>Xie</surname>
							<given-names>YM</given-names>
						</name><etal/>																																																										
				    </person-group>
					<year>1997</year>
					<article-title>Human immunodeficiency virus type 1 VpR interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair</article-title>
					<source>J Virol</source>
					<volume>71</volume>
					<fpage>9732</fpage>
					<lpage>9742</lpage>
				</citation>
			</ref>
			<ref id="r25">
				<citation citation-type="journal">
					<person-group>
						<name>
							<surname>Yu</surname>
							<given-names>XF</given-names>
						</name>
						<name>
							<surname>Matsuda</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Essex</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Lee</surname>
							<given-names>TH</given-names>
						</name>																																																										
				    </person-group>
					<year>1990</year>
					<article-title>Open reading frame VpR of simian immunodeficiency virus encodes a virion-associated protein</article-title>
					<source>J Virol</source>
					<volume>64</volume>
					<fpage>5688</fpage>
					<lpage>5693</lpage>
				</citation>
			</ref>
		</ref-list>		
	</back>
</article>
